Effect of the carbohydrate counting method on glycemic control in patients with type 1 diabetes by Dias, Viviane M et al.
RESEARCH Open Access
Effect of the carbohydrate counting method on
glycemic control in patients with type 1 diabetes
Viviane M Dias
*, Juliana A Pandini, Raquel R Nunes, Sandro LM Sperandei, Emilson S Portella, Roberta A Cobas,
Marília de B Gomes
Abstract
Background: The importance of achieving and maintaining an appropriate metabolic control in patients with type
1 diabetes mellitus (DM1) has been established in many studies aiming to prevent the development of chronic
complications. The carbohydrate counting method can be recommended as an additional tool in the nutritional
treatment of diabetes, allowing patients with DM1 to have more flexible food choices. This study aimed to
evaluate the influence of nutrition intervention and the use of multiple short-acting insulin according to the
carbohydrate counting method on clinical and metabolic control in patients with DM1.
Methods: Our sample consisted of 51 patients with DM1, 32 females, aged 25.3 ± 1.55 years. A protocol of
nutritional status evaluation was applied and laboratory analysis was performed at baseline and after a three-
month intervention. After the analysis of the food records, a balanced diet was prescribed using the carbohydrate
counting method, and short-acting insulin was prescribed based on the total amount of carbohydrate per meal
(1 unit per 15 g of carbohydrate).
Results: A significant decrease in A1c levels was observed from baseline to the three-month evaluation after the
intervention (10.40 ± 0.33% and 9.52 ± 0.32%, respectively, p = 0.000). It was observed an increase in daily insulin
dose after the intervention (0.99 ± 0.65 IU/Kg and 1.05 ± 0.05 IU/Kg, respectively, p = 0.003). No significant
differences were found regarding anthropometric evaluation (BMI, waist, hip or abdominal circumferences and
waist to hip ratio) after the intervention period.
Conclusions: The use of short-acting insulin based on the carbohydrate counting method after a short period of
time resulted in a significant improvement of the glycemic control in patients with DM1 with no changes in body
weight despite increases in the total daily insulin doses.
Introduction
Diabetes mellitus (DM) is considered a major public
health issue because of its increasing prevalence and
high morbidity and mortality. Recent data from the
World Health Organization (WHO) estimate that there
will be 333 million people with DM in the year of 2030,
and 11 million of these will be Brazilian people [1]. In
Brazil, the average prevalence of DM was 7.6% in people
aged 30-69 years in the 1980’s and 30-50% were undiag-
nosed cases [2]. Approximately 5-10% of people with
DM present type 1 diabetes (DM1).
Hyperglycemia is directly related to the development
and progression of microvascular complications in
patients with DM [3]. The effect of intensive insulin
treatment of the patients aiming to reduce A1c levels
has been shown to reduce the risk of diabetes microvas-
cular complications [4-6]. In addition, a study conducted
by Moss et al., with individuals with DM1 followed up
for 10 years, showed positive association between gly-
cated hemoglobin levels and coronary artery disease [7].
Based on these facts, the American Diabetes Association
(ADA) [8] emphasizes the importance of a good glyce-
mic control to prevent chronic diabetes complications
and suggests that changes in the diet composition of
patients with DM are relevant strategies to achieve an
appropriate metabolic control. * Correspondence: vivimonteirodias@gmail.com
Pedro Ernesto University Hospital (HUPE). Av. 28 de Setembro, n. 77, Vila
Isabel - Rio de Janeiro - CEP: 20551-030 - RJ - Brazil
Dias et al. Diabetology & Metabolic Syndrome 2010, 2:54
http://www.dmsjournal.com/content/2/1/54
METABOLIC SYNDROME
DIABETOLOGY & 
© 2010 Dias et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.One available strategy is the carbohydrate counting
method that allows patients to have a more flexible food
choice. This method has been used since 1935 in Eur-
ope and was adopted by The Diabetes Control and
Complication Trial (DCCT). The ADA, in 1994, recom-
mended this method as an additional tool in the nutri-
tional treatment of DM. It started to be used in Brazil
by few professionals in 1997, but nowadays many groups
use this method in a systematic way [9].
This study aimed to evaluate the influence of nutrition
intervention on the clinical and metabolic parameters in
patients with DM1, using multiple dose of short-acting
insulin according to the carbohydrate counting method.
Subjects and Methods
This study was conducted in outpatients with DM1 fol-
lowed up at Pedro Ernesto University Hospital [Hospital
Universitário Pedro Ernesto] (HUPE), diagnosed accord-
ing to the ADA criteria [10], aged 10-60 years. The
exclusion criteria were illiteracy, diabetic nephropathy
or retinopathy, pregnancy and mobility impairment. The
study protocol was approved by the Research Ethics
Committee of Pedro Ernesto University Hospital and a
consent form was signed by the participants.
Patients included in the study followed their normal
dietary prescription without having received any pre-
vious guidance on the carbohydrate counting of foods in
the diet.
Patients were evaluated at baseline and after a three-
month period of follow-up. At the first meeting, a pro-
tocol of nutritional status evaluation was applied and
blood samples were collected. The protocol consisted of
personal data, previous pathology history, family history,
information on type and dose of insulin used. The nutri-
tion evaluation consisted of anthropometric, biochemical
and dietary information.
The anthropometric parameters included measure-
ment of body weight (BW), stature, abdominal circum-
ference, and hip and waist circumference. A previously
tared Filizola® plataform scale, with 0.1 kg precision and
maximum capacity of 150 kg, was used to determine
BW. Before BW evaluation, shoes, all excessive clothes
and any object that could interfere with the precise BW
determination were removed. During this procedure,
patients maintained the feet at the centre of the scale,
the body erected with the weight distributed equally
between the two feet, without making any sort of move-
m e n t s ,w i t ht h ea r m sa l o n gt h eb o d ya n dt h eb a c k
turned to the display screen. Stature was determined
using a Tonelli & Gomes® stadiometer with graduation
of 0.1 cm, tested and approved by the pediatric endocri-
nology unit of the Federal University of Paraná. In order
to avoid bias, patients were without shoes, in orthostatic
position. During the evaluation, patients breathed in
profoundly while the examiner put the horizontal stem
of the stadiometer in the appropriate position (the high-
est point of the head). Based on BW and stature data,
body mass index (BMI) was calculated and used to clas-
sify adults according to the cut-offs proposed by the
World Health Organization (WHO, 1998) [11] as under-
weight (BMI under 18.5 kg/m
2), normal range (BMI
between 18.5 and 24.9 kg/m
2), pre-obese (BMI between
25.0 and 29.9 kg/m
2), obese class I (BMI between 30.0
and 34.9 kg/m
2), obese class II (BMI between 35.0 and
39.9 kg/m
2) and obese class III (BMI equal or above
40.0 kg/m
2). Children less than 10 years old did not par-
ticipate in this study. The BMI percentiles for teenagers
were those presented by Monteiro and Conde [12].
Abdominal circumference (AC) was measured at the
level of the umbilicus, and waist circumference (WC)
was measured at the medium point between the last
inferior rib and the iliac crest. Hip circumference (HC)
was measured in the widest point of the greater tro-
chanters. Patients stayed erected maintaining relaxed the
region that would be measured and without clothes. An
inelastic metric tape was used to obtain the measure-
ments mentioned above. Waist-to-hip ratio (WHR) was
calculated, dividing waist circumference by hip circum-
ference (both measurements in cm).
A blood collection sample was obtained after a mini-
mum of 10 hours fasting. The colorimetric enzymatic
method was used to determine plasma glycemia, total
cholesterol, HDL-cholesterol and triglyceride levels.
LDL-cholesterol was calculated by the Friedwald for-
mula in patients with triglycerides < 400 mg/dl [13].
Glycated hemoglobin analysis was performed by the
HLPC method (Hitachi Hech-9000 V.R.) with normal
range from 4.4 to 6.4%. Postprandial glycemia was eval-
uated two hours after the usual breakfast.
In order to evaluate dietary intake, patients filled out a
three-day food record (three consecutive days with one
day of the weekend), only at the baseline, in which they
described information about food intake, meal time and
places where meals were eaten. Complementary infor-
mation included addition of salt to the meals, intake of
refined sugar, oil, sauces, diet or light products, indus-
trialized food and the way meals were prepared. This
method is known as estimated record of food intake
since foods are estimated using measurement conversion
tables. Portions were determined in household measures
(spoons, cups, shallow or deep plates).
Records were made by the patient after being pre-
viously instructed and were reviewed by the dietitian
who analyzed the diet macronutrients centesimal com-
position using national tables of food composition
[14,15]. After the careful analysis of the records, a
balanced diet was prescribed based on the carbohydrate
counting method considering the food habits of the
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stitution food list.
Insulin dose was adjusted to the amount of carbohy-
drate in each meal based on the following relationship:
one unit of short-acting human insulin for every 15 g of
ingested carbohydrate. All participants used multiple
daily injections of short-acting insulin at meals with
NPH as basal and at night. The short-acting insulin
dose was prescribed before breakfast taking into account
breakfast and the mid-morning snack, the insulin dose
prescribed before lunch covered lunch and the mid-
afternoon snack, and the insulin dose prescribed before
dinner covered dinner and supper. No participant used
self-blood glucose monitoring during the study period.
Participants were followed up with visits to the dieti-
tian every 15 days, where dietary history was made to
verify adherence to the diet of carbohydrate counting.
We did not use any other tool for nutritional assessment
during the three-month follow-up period.
Data were collected and analyzed by the Statistical
Package for the Social Sciences (SPSS), version 13.0 for
Windows. All variables were tested for normality, and
data were presented as mean ± standard deviation.
Paired t-test was used to compare baseline, data were
collected after the three-month period, and p-value <
0.05 was considered statistically significant.
Results
Initially, 55 patients aged 25.3 ± 1.55 years took part in
the study. Four patients were excluded because they did
not attend the follow-up. Fifty-one patients with DM1
completed the study, 37% males and 63% females, with
duration of DM of 11.31 ± 1.09 years.
A significant decrease in A1c levels was observed from
baseline to the three-month evaluation (10.40 ± 0.33%
and 9.52 ± 0.32%, respectively, p = 0.0009). These data
are shown in Figure 1.
A significant reduction in A1c levels was observed in
38 (74%) patients. Conversely, 11 diabetics (21.5%) pre-
sented an increase in this value, whereas two patients
( 3 . 9 % )m a i n t a i n e dt h es a m eb a s e l i n ev a l u e s .T h ep r o -
portion of patients that presented A1c levels < 7% at
the baseline and after the intervention did not differ
[3 (5.9%) vs. 4 (7.5%) patients].
Additional biochemical analysis did not reveal any sig-
nificant difference. Baseline and post-treatment data are
described in detail in Tables 1 and 2, separated by
gender.
It was observed an increase in daily insulin dose/kg of
BW after the intervention, when compared to the base-
line values (1.05 ± 0.05 vs. 0.99 ± 0.65, respectively, p =
0.003). The short-acting insulin increase occurred in
all doses, at breakfast from 2.25 ± 5.12 to 3.81 ± 4.53
Figure 1 A1c values at baseline and after the intervention.
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0.00), and at dinner from 2.28 ± 1.89 to 3.32 ± 2.50
(p = 0.00). No significant differences were observed in
doses of NPH insulin at breakfast from 34.06 ± 12.06 to
34.20 ± 12.19 (p = 0.64), at lunch from 2.38 ± 5.83 to
1.82 ± 4.33 (p = 0.28), and at diner from 18.64 ± 12.18
to 19.16 ± 11.41 (p = 0.42).
No significant differences were found regarding the
anthropometric evaluation (BMI, WC, HC, AC and
WHR) after the intervention period. The values found at
baseline and three months after the therapeutic inter-
vention were, respectively: BMI, 22.87 ± 0.42 vs. 23.20 ±
0.47 Kg/m
2 (p = 0.51); WC 75.33 ± 1.04 vs. 74.98 ± 1.09
cm (p = 0.509); AC, 79.28 ± 1.23 vs. 79.40 ± 1.17 cm
Table 1 Clinical and laboratorial data of sample before and after the therapeutic intervention in all patients studied
Variables Baseline 3 months Significance level
(p)
n (number) 51 51
Gender(M/F) 19/32 19/32
Age(years) 25,3 ± 1,55 25,3 ± 1,55
Duration of diabetes (years) 11,31 ± 1,09 11,31 ± 1,09
BMI (kg/m
2) 22,87 ± 0,42 23,20 ± 0,47 0,51
sBP (mmHg) 111,3 ± 1,96
(180,0- 90,0)
111,24 ± 1,76
(180,0- 90,0)
0,81
sDP(mmhg) 70,24 ± 1,14
(90,0- 50,0)
90,03 ± 10,12
(100,0- 50,0)
0,32
A1c (%) 10,40 ± 0,33 9,52 ± 0,32 0,0009
A1c < 7% (n pacientes) 3 4
Cholesterol(mg/dl) 174,88 ± 5,58 169,94 ± 4,58 0,23
HDL-Cholesterol(mg/dl)
LDL- Cholesterol(mg/dl)
53,84 ± 1,94
210,58 ± 6,05
53,40 ± 1,91
202,72 ± 4,86
0,79
0,11
Triglycerides (mg/d) 93,23 ± 7,60 104,63 ± 10,29 0,07
Fasting blood sugar
FBS (mg/dl)
180,00 ± 21,22 168,82 ± 14,79 0,73
Postprandial glycemia (mg/dl) 256,78 ± 12,82 243,39 ± 15,92 0,46
Insulin dose/kg 0,99 ± 0,65 1.05 ± 0.05 0,00
NPH insulin dose 55,08 ± 22,34 55,18 ± 21,10 0,89
Rapid insulin dose 4,42 ± 8,72 11,73 ± 7,04 0,00
Table 2 Clinical and laboratorial data of sample before and after the therapeutic intervention, separated by gender
Variables Men Women
Baseline 3 months Significance
Level
(p)
Baseline 3 months Significance
level
(p)
n (number) 19 19 32 32
Duration of diabetes (years) 9,24 ± 1,41 9,24 ± 1,41 0,124 12,34 ± 1,48 12,34 ± 1,48 0,167
BMI (kg/m
2) 22,55 ± 0,62 22,88 ± 0,65 0,37 23,0 ± 0,57 23,0 ± 0,65 0,47
sBP (mmHg) 120 ± 0,75 110 ± 1,78 0,58 100,82 ± 0,29 110 ± 0,38 0,33
sDP(mmHg) 70,67 ± 1,23 70,75 ± 1,28 60,95 ± 1,04 90,59 ± 12,40
A1c (%) 10,28 ± 0,55 9,30 ± 0,50 0,01 10,00 ± 2,42 9,65 ± 2,45 0,00
Cholesterol(mg/dl) 159,63 ± 6,37 163,73 ± 5,70 0,164 183 ± 7,69 179,56 0,48
HDL- Cholesterol(mg/dl) 50,63 ± 3,63 49,18 ± 4,07 0,46 55,7 ± 2,19 55,90 ± 1,77 0,92
LDL- Cholesterol
(mg/dl)
193,71 ± 7,86 184,41 ± 6,13 0,13 220,59 ± 8,00 213,59 ± 6,13 0,32
Triglycerides (mg/dl) 89,73 ± 11,18 96,68 ± 14,25 0,49 95,31 ± 10,2 109 ± 14,15 0,09
Fasting blood sugar- (mg/dl) 153,84 ± 28,37 153,84 ± 28,37 0,74 200,34 ± 20,32 171,12 ± 18,85 0,25
Postprandial glycemia (mg/dl) 213,05 ± 16,83 231,47 ± 20,64 0,46 282 ± 16,32 250,46 ± 22,44 0,19
Insulin dose/kg 0,89 ± 0,31 1,05 ± 0,31 0,00 1,07 ± 0,53 1,13 ± 0,49 0,10
NPH insulin dose 55,22 ± 19,90 56,89 ± 18,52 0,16 55,00 ± 23,91 54,22 ± 22,65 0,40
Rapid insulin dose 3,65 ± 5,30 3,12 ± 2,34 0,67 4,84 ± 10,17 12,13 ± 7,77 0,00
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0.325) and WHR, 0.79 ± 0.0 vs. 0.78 ± 0.61 (p = 0.161).
Average calorie intake observed during the three days
of food record was higher than the average calorie
intake proposed by the prescribed diet based on carbo-
hydrate counting. There was a reduction in the carbohy-
drate percentage in food record when compared to the
amount recommended in the prescribed diet. On the
other hand, protein intake in food record surpassed the
amount in the prescribed diet. The comparison between
total calorie intake and the percentage of macronutrient
distribution in the three days of food record with the
values recommended by the prescribed diet are
described in Table 3 and Figure 2.
Discussion
Carbohydrate counting is not a diet but a method that
emphasizes glycemic control based on the use of multi-
ple doses of short-acting insulin according to carbohy-
drate intake in a meal [16].
The goal of the therapeutic plan of our study is the
appropriate adherence to the treatment aiming a meta-
bolic control.
The A1c levels were reduced significantly after the
study intervention, although they did not achieve the
established values for a good glycemic control. It is
known that a 1% fall in A1c results in significant
decrease in microvascular complications, as described by
DCCT [4] which compared the intensive treatment to
the conventional treatment. This reduction can yield a
more suitable clinical and metabolic control of the dia-
betes and, consequently, improve the lifestyle of these
patients [17]. The significant decrease in A1c levels in
our study allows us to conclude that adherence to the
diet was adequate.
We did not observe differences regarding fasting and
postprandial glycemia, mainly because both of them
represent isolated values and are highly influenced by
countless factors, and therefore are not good parameters
to evaluate glycemic control in DM1 owing to its great
variability [18].
No weight gain was observed during the intervention
period. Our study did not focus on intensive treatment
because self-monitoring blood glucose was not used.
However, weight gain coulds t e mf r o mt h em u l t i p l e -
dose insulin therapy [19]. Although patients had an
increase in the average of some anthropometric data
during intervention, none of them was significant, due
to the fact that the prescribed diet aimed at health
habits and was in accordance with the macronutrient
recommendations made by the Brazilian Society of Dia-
betes in 2007[20].
The increase in the insulin dose can be explained by
the multiple peaks of rapid-acting insulin schemes. The
administration of insulin in an intensive treatment
should seek to reproduce as close as possible the normal
physiologic insulin secretion, resulting in increase in the
number of peaks and in the units of insulin/kg BW.
Intensive insulin treatment, although beneficial in
decreasing the risk of diabetic complications, can result
in weight gain [21] and its consequences, such as hyper-
tension and a more atherogenic lipid profile.
Considering the great number of patients with DM1
who cannot afford intensive insulin therapy, including
patients of our sample, and that the distribution of gly-
cemic self-monitoring device by DATASUS (Data Pro-
cessing Company of the Unified Health System)
[Empresa de Processamento de Dados do Sistema Único
de Saúde] is irregular, the scheme proposed in this
study was multiple pre-adjusted doses of insulin based
on the amount of ingested carbohydrate. Even though it
is not the ideal, it can result in positive observations,
such as the reduction in A1c levels, as observed in our
study. Recently, Franco & Costa (2005) reported that
o n l yam i n o r i t yo fp a t i e n t sw i t hD M 1u s eh o m es e l f -
monitoring of glycemia [19].
There are many barriers for the use of glycemic self-
monitoring, such as the high cost and the physical and
psychological discomfort due to factors such as the
blood collection by finger prick, the technique misun-
derstanding by the patient or by the professionals, the
time available for the performance of the test, the inter-
pretation of individual data at different periods so as to
make the adequate adjustment of insulin doses accord-
ing to dietary intake [22].
Comparing the prescribed diet with the centesimal
analysis of food record, the distribution of macronutri-
ents in the prescribed diet was within the recommended
range for diabetics [23]. The prescribed diet preferred
complex carbohydrate, low glycemic index food, low fat
food and high fiber food, characterizing health food
habits. According to Brand-Miller et al. (2002), high gly-
cemic index food is related to hyperphagia and, conse-
quently, obesity [23].
Table 3 Caloric intake and nutritional composition of diet
of Carbohydrate counting and food register
Baseline (base don food
register)*
Prescribed diet p
Kcal 1694,33 ± 517,32 1588,49 ± 41,24 0,43
Carbohydrates
(%)
60,12 ± 21,75 51,70 ± 6,91 0,004
Protein (%) 16,44 ± 12,23 22,38 ± 3,01 0,001
Lipides (%) 23,44 ± 13,83 25,92 ± 4,57 0,20
* without intervention for carbohydrate counting method
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insulin, the most used type of insulin in our country.
This scheme is not usually reported in the literature in
studies on glycemic control, which use more frequently
insulin analogues, such as insulin lispro, insulin glusiline,
ultra slow regular insulin and insulin aspart [24-27].
Considering the limitations of our study, it is note-
worthy to state that improvement of glycemic control
was not sufficient for achieving appropriate control (A1c
< 7%), possibly because of the short period of interven-
tion and the high levels of A1c at baseline. Additional
time of follow-up could determine if this improvement of
glycemic control would persist or stabilize. The absence
of a control group was also a limitation of our study.
A second and significant limitation of this study is
related to the fact that the monitoring of blood glucose
was not carried out, so we had no data to characterize
hypoglycemia, which is a common intercurrence in
patients with multiple needle sticks and carbohydrate
counting. Such data would certainly enrich our results.
Conclusion
The intervention through the carbohydrate counting
method produced a significant improvement of glycemic
control in type 1 diabetic patients, even though it was
not sufficient to reach an adequate glycemic control.
Our results allow us to conclude that it is possible to
use the carbohydrate counting method successfully
without home self-monitoring. This fact should be con-
sidered in developing countries like Brazil where a good
metabolic control is a difficult goal to be reached
because of socioeconomic factors such as expensive
blood tests strips for monitoring blood glucose and irre-
gular supply of oral tablets and insulin by the national
health care system.
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